The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXlmedia Regulatory News (XLM)

Share Price Information for Xlmedia (XLM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.50
Bid: 13.00
Ask: 14.00
Change: 0.25 (1.89%)
Spread: 1.00 (7.692%)
Open: 13.25
High: 13.60
Low: 12.75
Prev. Close: 13.25
XLM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - XLMedia Plc

15 Apr 2016 12:10

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: HARGREAVE HALE LIMITED (for Discretionary Clients)
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

XLMEDIA PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A
(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

14 APRIL 2016
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

NO

If YES, specify which:

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: ORDINARY USD 0.000001

Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 5,775,000 2.8824
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

5,775,000 2.8824

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit
ORDINARY SALE 100,000 73.528p

(b) Cash-settled derivative transactions

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit
NONE

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit
NONE

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)
NONE

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 15 APRIL 2016
Contact name: DAVID CLUEIT

HARGREAVE HALE LTD

Telephone number: 01253 754739

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160415005344/en/

Copyright Business Wire 2016

Date   Source Headline
22nd Jun 20221:25 pmRNSPDMR and PCA Share Purchase
16th Jun 20224:41 pmRNSSecond Price Monitoring Extn
16th Jun 20224:36 pmRNSPrice Monitoring Extension
10th Jun 202212:34 pmRNSResult of AGM
27th May 20227:00 amRNSAppointment of Chief Executive Officer
26th May 20227:00 amRNSGrant of Share Awards
19th May 20225:30 pmRNSPosting of Annual Report and Notice of AGM
10th May 20227:00 amRNSSports Content Partnership with Advance Local
4th Apr 20227:00 amRNSDirectorate Change
31st Mar 20227:00 amRNSAppointment of Chair
30th Mar 20229:05 amRNSSecond Price Monitoring Extn
30th Mar 20229:00 amRNSPrice Monitoring Extension
29th Mar 20227:00 amRNSFinal Results
24th Mar 20228:40 amRNSHolding(s) in Company
21st Mar 20227:00 amRNSAppointment of Chief Financial Officer
9th Mar 20227:00 amRNSNotice of Results
4th Mar 202211:05 amRNSSecond Price Monitoring Extn
4th Mar 202211:00 amRNSPrice Monitoring Extension
28th Feb 20227:00 amRNSAppointment of Interim-Chair
1st Feb 202211:06 amRNSSecond Price Monitoring Extn
1st Feb 202211:01 amRNSPrice Monitoring Extension
1st Feb 20227:00 amRNSTrading Update
24th Jan 20224:41 pmRNSSecond Price Monitoring Extn
24th Jan 20224:36 pmRNSPrice Monitoring Extension
19th Jan 20227:00 amRNSDirectorate Change
3rd Nov 20215:35 pmRNSDirector Share Purchase
2nd Nov 20213:55 pmRNSAppointment of Chief Financial Officer
27th Oct 20217:20 amRNSDirector Share Purchase
15th Oct 20217:00 amRNSAppointment of Non-Executive Director
23rd Sep 20213:00 pmRNSDirector Share Purchase
23rd Sep 20217:01 amRNSAcquisition of BlueClaw Media Limited
23rd Sep 20217:00 amRNSResults for the six months ended 30 June 2021
7th Sep 20217:00 amRNSNotice of Results and Analyst Presentation
2nd Sep 20217:00 amRNSAcquisition of Saturday Football Inc
26th Jul 20217:00 amRNSTrading Update
8th Jul 202112:32 pmRNSBoard change
29th Jun 20217:00 amRNSAppointment of Chief Information Officer
16th Jun 20218:00 amRNSAppointment of Non-Executive Director
27th May 202111:10 amRNSResult of AGM
27th May 20217:00 amRNSAGM Statement
17th May 202110:16 amRNSHolding(s) in Company
6th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
30th Apr 202112:43 pmRNSTotal Voting Rights
30th Apr 20219:42 amRNSGrant of Share Awards
27th Apr 20217:00 amRNSResults for the Year Ended 31 December 2020
23rd Apr 20217:00 amRNSNotice of Results
12th Apr 20217:00 amRNSHolding(s) in Company
6th Apr 20212:10 pmRNSResults of General Meeting & Open Offer
1st Apr 20215:18 pmRNSTotal Voting Rights
26th Mar 20217:00 amRNSGrant of Share Awards

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.